Could New Non-Hodgkin Lymphoma Drugs Mean Less Chemo in the Future?

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated May 31st, 2023

Could New Non-Hodgkin Lymphoma Drugs Mean Less Chemo in the Future?

NOW
PLAYING
Amid Hollywood Parking Lot Paparazzi, Courageous 'Baywatch' Alum Nicole Eggert, 52, Rocks a Shaved Head From Chemo
NOW
PLAYING
Actor Ken Jeong’s Love For Wife, as a Mom and Breast Cancer Survivor
NOW
PLAYING
The Drug Anktiva Plus BCG for Early-Stage Bladder Cancer Treatment Offers A Good Non-Surgical Option
NOW
PLAYING
Rising Above Petty Drama, Housewives Stars Guerdy Abraira, 46, Says There’s No ‘Bad Blood’ With Larsa Pippen, 49, After She Revealed Cancer Diagnosis Without Permission
NOW
PLAYING
Groundbreaking CAR T-Cell Therapy Approved For Earlier Use in Relapsed Myeloma Patients
NOW
PLAYING
FDA Approves Breyanzi - The First and Only CAR-T Cell Therapy To Show Promise For CLL Patients

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... non-hodgkin lymphoma trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.